LDL-c Key Lessons

Recent

Key lessons on LDL-c and CV risk

LDL-c Key lessons

Screening for familial hypercholesterolemia after ACS pays off

LDL-c Key Lessons

LDL-c lowering treatment impacts disease progression before clinical manifestation

LDL-c Key Lessons

After an event, initiate the right treatment in hospital

LDL-c Key Lessons

Key lessons on LDL-c and CV risk

LDL-c Key lessons

Key messages on LDL-c biology and therapeutic considerations in relation to CV risk were formulated based on discussions among European lipid experts.

Screening for familial hypercholesterolemia after ACS pays off

LDL-c Key Lessons

LDL-c lowering treatment impacts disease progression before clinical manifestation

LDL-c Key Lessons

After an event, initiate the right treatment in hospital

LDL-c Key Lessons

When statin therapy is discontinued, the risk of CV events and mortality increases

LDL-c Key Lessons

Statin therapy is remarkably safe

LDL-c Key Lessons

Greatest risk reduction can be achieved in the highest risk groups

LDL-c Key Lessons

Even below LDL-c target (<70 mg/dL), further LDL-c reduction gives additional CV benefit

LDL-c Key Lessons

Use combination therapy for additive LDL-c lowering effect to reduce CV risk

LDL-c Key Lessons

Lowering LDL-c profoundly to very low levels is safe

LDL-c Key Lessons

When lowering plasma cholesterol, this does not affect cholesterol present in membranes

LDL-c Key Lessons

Side effects are not the effect of LDL-c lowering and achieved LDL-c level

LDL-c Key Lessons